The effect of hypertension, diabetes, and smoking on the levels of some biochemical parameters in chronic renal failure patients
Article Sidebar
Main Article Content
Abstract
This study has been acomblished between December 2016 and September 2017 which included 70 patients with chronic renal failure who attended at Al-yarmuke teaching hospital in Baghdad with25 healthy individual as control. The research aims to study the effect of hypertension, diabetes and smoking on the levels of some biochemical parameters of chronic renal failure patients comparing with healthy control .The results showed a significant increase in the concentrations of urea, creatine, uric acid, cholesterol, Triglycerides(TG), low density lipoproteins (LDL) and Very low density lipoproteins (VLDL), compared to healthy control. The results also showed that hypertension has an effect on the concentration of urea, uric acid, creatinine, cholesterol, Triglycerides (TG), low density lipoproteins (LDL) and Very low density lipoproteins (VLDL), the results indicated that the diabetes has effects on the concentration of urea, creatinine, cholesterol and Triglycerides (TG), High density lipoproteins (HDL), low density lipoproteins( LDL) and Very Low density lipoproteins (VLDL) with no effects on the concentration of uric acid. There was an effect of smoking on The concentrations of cholesterol and the Triglycerides(TG), low Density Lipoproteins( LDL), Very Low density Lipoproteins (VLDL), urea, uric acid, and creatinine .The gender has no effect on the concentration of all measured parameters except on TG concentration.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Mannangi, N. and Jayasree, S. (2014). Lipoprotein (a) & Lipid profile in chronic kidney disease. Case control study, Web med Central biochemistry, 5(2): WMC004568.
[2] Katrin, U. et al. (2005). Factors Associated With Lipoporotein (a) in Chronic Kidney Disease. American Journal of Kidney Diseases, 45: 28-38.
[3] Azra, K. (2014). Estimation of blood urea (BUN) and serum creatinine level in patient of renal disorder. Indian Journal of Fundamental and Applied Life Sciences ISSN., 4(4).
[4] Dwinnell, B.G. and Anderson, R.J. (2012). Diagnostic Evaluation of the Patient with Acute Renal Failure, Atlas of Diseases of the Kidney. ISN Informatics Commission and NKF cyber Nephrology.
[5] Zoccali, C. and Mallamaci, F. (2013). Uric Acid, hypertension, and cardiovascular & renal complications. Curr Hypertens Rep., 15(6): 531-7.
[6] Nitin, S.N. and Jayshree, V.G. (2011). Lipid Profile and Serum Paraoxonase1 Activity in CRF Patients Pre and Posthemodialysis, Al Ameen Journal Med Sci., 4(1): 61-68.
[7] Warnick, G.R.; Knopp, R.H.; Virginia, F. and Lance, B. (1990). Estimating low– density lipoprotein cholesterol by Friedewald equation is adequate for classifying patients on basis of nationally recommended cut points, Clin Chem., 36(1): 15-19.
[8] Sharma, A.; Hirulkar, NB.; Wadel, P. and Das, P. (2011). Influence of Hyperglycemia on Renal Function Parameters in Patients with Diabetes Mellitus. International Journal of Pharmaceutical & Biological Archives.
[9] Noor, U.A.; Raja, T.M.; Javaid, M.A.; Mudassar, Z. and Asad, M.R. (2014). Evaluating Urea and Creatinine Levels in Chronic Renal Failure Pre and Post Dialysis: A Prospective Study. Journal of cardiovascular disease, 2(2).
[10] Moses, O. and Johnkennedy, N. (2013). The Alteration of Serum Glucose Urea and Creatinine Level of Malaria Patients in Obowo Local Government Area of Imo State Nigeria. International Journal of Advanced Medicine, (1): 1-6.
[11] Christopher, E. and Ernest, A. (2014). Abnormal serum uric acid levels in health and disease: A double-edged sword. American Journal of Internal Medicine, 2(6): 113-130.
[12] David, G. and Robert, U. (2013). The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality, BMC Nephrology, 14: 164.
[13] Mehmet, E. (2014). The association between serum uric acid level and heart failure and mortality in the early period of STEMI. Turkish Society of Cardiology, 42(6): 509-510.
[14] Guyton, A.C. et al. (1996). The dominant role of the Kidneys in long-term Arterial pressure regulation in normal and hypertensive states. In Laragh J. H., and Brenner, B.M.: Pathophysiology, Diagnosis and Management of hypertension. New York, Raven Press: p921.
[15] Prospective studies collaboration, (2002), "Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies", Lancet, 360: p1903-1913.
[16] Lubanski, M.S.; McCullough, P.A., (2009). Kidney’s role in hypertension. Minerva Cardioangiol. (57):743–759.
[17] Mennuni, S. et al. (2014). Hypertension and kidneys: Unraveling complex molecular mechanisms underlying hypertensive renal damage. Journal Hum. Hypertens, (28):74–79.
[18] Kurts, C.; Panzer, U.; Anders, H.J. and Rees, A.J. (2013). The immune system and kidney disease: Basic concepts and clinical implications. Nat. Rev. Immunol, (13):738–753.
[19] Watatnabe, S.; Kang, D.; Heng, L.; Nakagawa, T. and Kanellis, J. (2002). Uric acid, hominoid. Evaluation, and the pathogenesis of Sahsensitivity, hypertension, (40):355-360.
[20] Ansari, A.G. (2003). Hypertensive kidney disease. JAMA, 13(2):110.
[21] Kik, k.R.; Koya, D. and Haneda, M. (2003), Progression of Diabetic nephropathy. AM.J. kidney Disease, (41):21.
[22] Rajapurkar, M. and Dabhi, M. (2010). Burden of disease-prevalence and incidence of renal disease in India. Clinical Nephropathy, (74):9-12.
[23] Stefanovic, V. and Milojkovic, M. (2004). Treatment of dyslipidemia in chronic kidney disease. Int Journal Artif Organs, (27):821–827.
[24] Moorehead, J.F.; Chan, M.K.; EL-nahas, M. and Varghese, Z. (1982). Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet (II):1309–1311.
[25] Aleix, C. and Elisabet, C. (2005). Dyslipidemia and the progression of renal disease in chronic renal failure patients, Kidney International, 68, Supplement (99): S87–S93.
[26] Crook, E.D. et al. (2003). Lipid abnormalities and renal disease: Is dyslipidemia a predictor of progression of renal disease. Am Journal Med Sci., (325):340–348.
[27] Kurella, M.; LO, JC. and Chertow, GM. (2005). Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Journal Am Soc. Nephrol, (16):2134–2140.
[28] Vaziri, N.D. and Moradi. H. (2006). Mechanisms of Dyslipidemia of chronic renal failure. Hemodialysis International, (10):1–7.
[29] Vaziri, ND.; Liang, K. and Parks, JS.; (2001). Down regulation of hepatic lecithin: cholesterol acyltransferase gene expression in chronic renal failure. Kidney Int, (59):2192-6.
[30] Vaziri, N.D. (2006). Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am Journal Physiol Renal Physiol, (290):F262–F272.
[31] Lokesh, R.M.S.; Anwar M.M. and Sandhya A.S. (June. 2016). Study of Lipid Profile in Chronic Renal Failure Patients Undergoing Hemodialysis, IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 15(6) Ver. II: 01-03.
[32] Rao, A.M.; Bitla, A.R.; Reddy, E.P.; Sivakumar, V. and Srinivasa, R.P. (2010). Lipid abnormalities, lipoprotein (a) and apoprotein pattern in non-dialyzed patients with chronic kidney disease, Indian Journal of Clinical Biochemistry, 25(1):47-50.
[33] Bhagwat, R.; Joshi, SP.; Satgia, P.; Rajesh, B. and Pradeep, S. (1997). Lipid abnormalities in CRF. Ind. Journal Clin. Biochem., 12(1):81-5.